Do statins interfere with muscle growth or exercise performance, and how do ezetimibe and bempedoic acid compare?

Statins can cause muscle symptoms, but a possible side effect is not proof that everyone taking one loses strength or stops building muscle. In STOMP, six months of high-dose atorvastatin produced more myalgia than placebo without an average reduction in measured muscle strength or exercise performance. That study did not directly test bodybuilding hypertrophy, and individual symptoms still matter. New weakness or pain should prompt assessment of the drug, interactions, training load and other causes rather than an assumption that every post-workout ache is statin injury.[1]

Ezetimibe reduces intestinal cholesterol absorption, while bempedoic acid acts on a liver cholesterol-synthesis pathway. Neither should be advertised as a proven muscle-building alternative. They provide different options when additional LDL lowering is needed or a statin is not tolerated. CLEAR Outcomes demonstrated cardiovascular benefit with bempedoic acid in statin-intolerant patients, while also reporting more gout and cholelithiasis. The appropriate comparison is LDL lowering, event evidence, individual tolerability and adverse effects, not a claim that one class is completely free of tradeoffs.[2][3]